Brief: Mira Pharmaceuticals - Alan Weichselbaum To Step Down As CFO Effective June 6, 2026 - SEC Filing
08/06/2026 22:17
BRIEF-Mira Pharmaceuticals - Alan Weichselbaum To Step Down As CFO Effective June 6, 2026 - SEC Filing June 8 (Reuters) - Mira Pharmaceuticals Inc MIRA.O:
MIRA PHARMACEUTICALS - ALAN WEICHSELBAUM TO STEP DOWN AS CFO EFFECTIVE JUNE 6, 2026 - SEC FILING
MIRA PHARMACEUTICALS - APPOINTS ANDRIY MUSHAK AS FRACTIONAL CFO EFFECTIVE JUNE 6, 2026 - SEC FILING
Source text: [ID:n0001493152-26-027751]
Further company coverage: MIRA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mira Pharmaceuticals
See all newsBrief: Mira Pharmaceuticals - Alan Weichselbaum To Step Down As CFO Effective June 6, 2026 - SEC Filing
Brief: MIRA Pharmaceuticals Secures Worldwide Exclusive Rights To MIRA-55 And SKNY-1 - SEC Filing
Brief: Mira Pharmaceuticals Enters Into Amendment No 1 To Exclusive License Agreement With Miralogx
Brief: Mira Pharmaceuticals Inc - Completes Phase 1 Dosing Of Ketamir-2 - SEC Filing
Brief: Mira Pharmaceuticals Inc - Initiates Phase 1 Study Of Ketamir-2 - SEC Filing